Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abigail Felix

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Market Access & Health Policy|May 27, 2016
Are payers treating orphan drugs differently?Joshua P Cohen, Abigail Felix
The Nurse Practitioner|June 19, 2019
Pediatric metabolic syndromeAbigail Felix, Rita Marie John
The American Journal of Managed Care|April 18, 2014
Complying with state and federal regulations on essential drug benefits: implementing the Affordable Care ActJoshua P Cohen, Abigail Felix, Magdalini Vasiadi
Clinical Therapeutics|July 6, 2015
Impact of Postapproval Evidence Generation on the Biopharmaceutical IndustryChristopher-Paul Milne, Joshua P Cohen, Abigail Felix, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Market Access & Health Policy|May 27, 2016
Are payers treating orphan drugs differently?Joshua P Cohen, Abigail Felix
The Nurse Practitioner|June 19, 2019
Pediatric metabolic syndromeAbigail Felix, Rita Marie John
The American Journal of Managed Care|April 18, 2014
Complying with state and federal regulations on essential drug benefits: implementing the Affordable Care ActJoshua P Cohen, Abigail Felix, Magdalini Vasiadi
Clinical Therapeutics|July 6, 2015
Impact of Postapproval Evidence Generation on the Biopharmaceutical IndustryChristopher-Paul Milne, Joshua P Cohen, Abigail Felix, et al.
Pageof 1